NOC

Business profile & competitive position

Northrop Grumman Corporation operates in the Industrials sector, specifically the Aerospace & Defense industry. The company designs, develops, and produces advanced defense and aerospace systems, including manned and autonomous aircraft platforms, space systems, mission systems, and cyber solutions. Its customer base is dominated by the U.S. Department of Defense and allied governments, with revenue typically contracted over multi-year or multi-decade timelines.

The financial returns support the view of a durable competitive position. A 26.6% ROE signals effective capital deployment relative to the equity base, while the 10.5% net margin reflects both pricing discipline and execution on technically complex programs. These figures are consistent with a contractor that occupies critical positions on strategically important franchises—such as the Sentinel strategic deterrent and integrated missile defense architectures—that are protected by high technical barriers to entry and long funding horizons. The $7.6 billion Sentinel surge detailed in recent coverage and the $3 billion missile-interceptor production agreements illustrate the scale of work tied to these franchises.

Financial posture

Northrop Grumman carries an $81.2 billion market capitalization and trades at a P/E ratio of 18.1. That valuation reads alongside a 10.5% net margin and a 26.6% ROE, framing the stock as neither deeply discounted nor stretched relative to its current profitability profile. The multiple gives investors a straightforward yardstick: they are paying roughly eighteen times trailing earnings for a company converting roughly one dime of every revenue dollar into net income.

One of the more distinctive metrics in the current snapshot is the beta of -0.10. Over the measured period, the stock has moved slightly inversely to the broader market, a pattern more commonly associated with regulated utilities or contracted-revenue businesses than industrials. For a defense prime with multi-year backlog visibility, that profile is logically consistent with cash flows that are seen as less sensitive to short-term economic cycles. The current price of $571.58 sits above a 50-day EMA of $547.95, and the RSI at 66.3 is approaching commonly watched overbought thresholds, though neither level in itself predicts direction.

Macro & geopolitical exposure

As an Aerospace & Defense company, Northrop Grumman's revenue trajectory is tied to U.S. defense appropriations, allied military spending, and the geopolitical threat environment rather than consumer discretionary demand. The industry is exposed to shifts in federal budget priorities, procurement cycles, and congressional authorization timelines, where program delays, cuts, or rephasing can alter multi-year revenue expectations.

Other macro levers include trade policy and supply-chain security. Defense platforms rely on specialized components—advanced semiconductors, rare-earth materials, precision castings, and secure electronics—where export controls, sanctions, or tariffs can affect both cost structures and delivery schedules. Currency risk is generally limited because the majority of revenue is dollar-denominated, though international contracts can introduce modest translation impacts. Regulatory compliance, cybersecurity requirements, and classified-program security protocols also represent persistent operating constraints across the sector, adding fixed overhead but also raising barriers to new entrants.

Recent developments

Recent headlines frame Northrop Grumman around two related themes: strategic deterrent modernization and missile-defense expansion. On August 8, 2026, Seeking Alpha published "Northrop Grumman Q2 2026: The Strategic Moat Widens Amid A $7.6B Sentinel Surge," highlighting the reported scale of the Sentinel program contribution. Two days earlier, on August 6, 2026, Zacks asked whether Northrop Grumman is a top-ranked momentum stock, reflecting the technical backdrop rather than any fundamental buy or sell verdict.

On August 3, 2026, Reuters reported that the U.S. had signed a deal to boost production of missile-interceptor parts, and on the same day GlobeNewswire carried Northrop Grumman's announcement that it had entered into $3 billion in landmark agreements to accelerate missile-interceptor production. Taken together, these items point to a portfolio increasingly weighted toward nuclear modernization and integrated missile defense—program categories that tend to carry multi-decade funding commitments and are less vulnerable to annual budget volatility.

Earnings behavior & post-earnings drift

Northrop Grumman has beaten earnings estimates in 7 of the last 8 reported quarters, an 88% beat rate, with an average earnings surprise of 6.5%. The average 5-day price move following those reports is 1.23%, classified as an upward drift.

The last four quarters illustrate the nuance behind those averages. On July 21, 2026, the company reported EPS of $7.68 against an estimate of $6.82—a 12.6% surprise—and the stock rose 2.54% the next day and 7.21% over the following five sessions. By contrast, the April 21, 2026 report delivered a $6.14 actual EPS versus a $6.06 estimate, only a 1.3% beat, and the stock fell 3.52% the next day and 5.45% over five days. The January 27, 2026 quarter saw a 3.6% beat ($7.23 vs. $6.98), producing a 1.53% next-day gain and a 3.87% five-day gain. Even the largest beat in the group—a 19.1% surprise on October 21, 2025 ($7.67 vs. $6.44)—produced a muted -0.48% next-day reaction and a -0.72% five-day drift.

This dispersion shows that beating the consensus is not the only variable priced into the post-earnings move; the magnitude of the beat, forward guidance, segment margins, and the stock's pre-report positioning all influence how investors reset expectations. The consensus EPS estimate for the next report, scheduled before market open on October 20, 2026, is $7.14.

For a deeper dive into institutional sentiment and the complete consensus breakdown around Northrop Grumman's October 2026 earnings report, readers can review the full institutional verdict on the ticker page.